Harnessing the Microbiome for Disease Prevention and Therapy | EK12
Short Talk: Microbiome‑Based Biomarker Predicts Response to Immune Checkpoint Inhibitor Therapy Independently of Clinical Features in a Melanoma Meta Cohort
Jan 19, 2021 12:30pm ‐ Jan 19, 2021 12:45pm
, MS, Second Genome
You must be logged in and own this session in order to post comments.
© 2022 Keystone Symposia & Digitell, Inc. All Rights Reserved